PubMed (GeneRIF) for id: 4189

Year	Number of Results
2008	1
2014	1
2015	1
2017	1
2019	5
2020	4
2021	2
2023	1
2024	0

1

Expression of DNAJB9 and some other genes is more sensitive to SWCNTs in normal human astrocytes than glioblastoma cells.

Minchenko DO, Rudnytska OV, Khita OO, Kulish YV, Viletska YM, Halkin OV, Danilovskyi SV, Ratushna OO, Minchenko OH. Minchenko DO, et al. Endocr Regul. 2023 Aug 10;57(1):162-172. doi: 10.2478/enr-2023-0020. Print 2023 Jan 1. Endocr Regul. 2023. PMID: 37561833 Free article.

2

DNAJB9 suppresses the metastasis of triple-negative breast cancer by promoting FBXO45-mediated degradation of ZEB1.

Kim HY, Kim YM, Hong S. Kim HY, et al. Cell Death Dis. 2021 May 8;12(5):461. doi: 10.1038/s41419-021-03757-x. Cell Death Dis. 2021. PMID: 33966034 Free PMC article.

3

DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients.

Said SM, Leung N, Alexander MP, Cornell LD, Fidler ME, Grande JP, Herrera LH, Sethi S, Zhang P, Nasr SH. Said SM, et al. Kidney Int. 2020 Aug;98(2):498-504. doi: 10.1016/j.kint.2020.02.025. Epub 2020 Mar 28. Kidney Int. 2020. PMID: 32622524

4

Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker.

Liang S, Chen D, Liang D, Xu F, Zhang M, Yang F, Zhu X, Li P, Zeng C. Liang S, et al. J Nephrol. 2021 Jun;34(3):883-892. doi: 10.1007/s40620-020-00783-4. Epub 2020 Jun 18. J Nephrol. 2021. PMID: 32557205

5

Hepatic DNAJB9 Drives Anabolic Biasing to Reduce Steatosis and Obesity.

Sun F, Liao Y, Qu X, Xiao X, Hou S, Chen Z, Huang H, Li P, Fu S. Sun F, et al. Cell Rep. 2020 Feb 11;30(6):1835-1847.e9. doi: 10.1016/j.celrep.2020.01.043. Cell Rep. 2020. PMID: 32049014 Free article.

6

Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia.

Wang D, Zeng T, Lin Z, Yan L, Wang F, Tang L, Wang L, Tang D, Chen P, Yang M. Wang D, et al. Biomed Pharmacother. 2020 Mar;123:109802. doi: 10.1016/j.biopha.2019.109802. Epub 2019 Dec 26. Biomed Pharmacother. 2020. PMID: 31884339 Free article.

7

Unstructured regions in IRE1α specify BiP-mediated destabilisation of the luminal domain dimer and repression of the UPR.

Amin-Wetzel N, Neidhardt L, Yan Y, Mayer MP, Ron D. Amin-Wetzel N, et al. Elife. 2019 Dec 24;8:e50793. doi: 10.7554/eLife.50793. Elife. 2019. PMID: 31873072 Free PMC article.

8

Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR.

Huang Y, Arora K, Mun KS, Yang F, Moon C, Yarlagadda S, Jegga A, Weaver T, Naren AP. Huang Y, et al. Sci Rep. 2019 Jul 8;9(1):9808. doi: 10.1038/s41598-019-46161-4. Sci Rep. 2019. PMID: 31285458 Free PMC article.

9

New developments in the diagnosis of fibrillary glomerulonephritis.

Nasr SH, Fogo AB. Nasr SH, et al. Kidney Int. 2019 Sep;96(3):581-592. doi: 10.1016/j.kint.2019.03.021. Epub 2019 Apr 9. Kidney Int. 2019. PMID: 31227146 Free article. Review.

10

Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients.

Nasr SH, Dasari S, Lieske JC, Benson LM, Vanderboom PM, Holtz-Heppelmann CJ, Giesen CD, Snyder MR, Erickson SB, Fervenza FC, Leung N, Kurtin PJ, Alexander MP. Nasr SH, et al. Kidney Int. 2019 May;95(5):1269-1272. doi: 10.1016/j.kint.2019.01.024. Epub 2019 Mar 1. Kidney Int. 2019. PMID: 31010480 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year